Related Experiment Video
Updated: Jun 29, 2025

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice
Published on: November 27, 2019
Dietary fasting and time-restricted eating in Huntington's disease: therapeutic potential and underlying mechanisms
Russell G Wells1, Lee E Neilson2,3, Andrew W McHill4,5
1Department of Neurology, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd, Portland, OR, 97239, USA. wellsru@ohsu.edu.
Insights
Time-restricted eating (TRE), a form of intermittent fasting, may offer a novel therapeutic strategy for Huntington's disease (HD). This lifestyle intervention shows potential for clearing toxic proteins and improving cellular functions implicated in HD progression.
Area of Science:
- Neuroscience
- Genetics
- Metabolic Disorders
Background:
- Huntington's disease (HD) is a fatal neurodegenerative disorder caused by a CAG repeat expansion in the huntingtin gene, leading to mutant huntingtin (mHTT) protein aggregation.
- Current treatments for HD are largely symptomatic, highlighting the urgent need for disease-modifying therapies and lifestyle interventions.
- Time-restricted eating (TRE), a dietary approach involving a daily eating window, has emerged as a potential intervention for neurodegenerative conditions.
Purpose of the Study:
- To explore the potential therapeutic role of time-restricted eating (TRE) in managing Huntington's disease (HD).
- To elucidate the underlying physiological mechanisms by which TRE may mitigate HD pathology.
- To assess the feasibility of TRE as a lifestyle intervention for individuals with HD.
Main Methods:
- Review of existing scientific literature on TRE and its effects on cellular pathways relevant to neurodegeneration.
- Analysis of proposed mechanisms by which TRE could impact mHTT clearance, mitochondrial function, and circadian rhythms in the context of HD.
- Examination of preclinical data suggesting TRE's benefits in HD models.
Main Results:
- TRE demonstrates potential to improve mitochondrial function, enhance autophagy, and reduce oxidative stress, all critical factors in HD pathogenesis.
- TRE may facilitate the clearance of mutant huntingtin (mHTT) protein aggregates.
- The intervention could restore striatal brain-derived neurotrophic factor (BDNF) levels and synchronize circadian rhythms, potentially alleviating HD symptoms.
Conclusions:
- Time-restricted eating (TRE) presents a promising, non-pharmacological approach to potentially slow Huntington's disease progression.
- Understanding TRE's impact on mHTT clearance, cellular stress, and circadian rhythms is key to developing effective lifestyle interventions for HD.
- Further clinical trials are essential to validate the safety and efficacy of TRE in human patients with Huntington's disease.
Abstract:
Huntington's disease (HD) is a devastating neurodegenerative disorder caused by aggregation of the mutant huntingtin (mHTT) protein, resulting from a CAG repeat expansion in the huntingtin gene HTT. HD is characterized by a variety of debilitating symptoms including involuntary movements, cognitive impairment, and psychiatric disturbances. Despite considerable efforts, effective disease-modifying treatments for HD remain elusive, necessitating exploration of novel therapeutic approaches, including lifestyle modifications that could delay symptom onset and disease progression. Recent studies suggest that time-restricted eating (TRE), a form of intermittent fasting involving daily caloric intake within a limited time window, may hold promise in the treatment of neurodegenerative diseases, including HD. TRE has been shown to improve mitochondrial function, upregulate autophagy, reduce oxidative stress, regulate the sleep-wake cycle, and enhance cognitive function. In this review, we explore the potential therapeutic role of TRE in HD, focusing on its underlying physiological mechanisms. We discuss how TRE might enhance the clearance of mHTT, recover striatal brain-derived neurotrophic factor levels, improve mitochondrial function and stress-response pathways, and synchronize circadian rhythm activity. Understanding these mechanisms is critical for the development of targeted lifestyle interventions to mitigate HD pathology and improve patient outcomes. While the potential benefits of TRE in HD animal models are encouraging, future comprehensive clinical trials will be necessary to evaluate its safety, feasibility, and efficacy in persons with HD.
Related Concept Videos
Metabolic States of the Body: Fasting and Starvation
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Regulation of Food Intake

